Newsroom
Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Updates
By KlickAnalytics Data Insights | December 31, 2024 08:02PM ET
Key Points
- Investors who suffered losses in Cassava Sciences, Inc. (SAVA) urged to act before February 10, 2025
- Class action lawsuits filed against Cassava Sciences, Inc. by multiple law firms
- Defendants accused of violating federal securities laws between February 7, 2024, and November 24, 2024
- Shareholders advised to contact Levi & Korsinsky, Pomerantz Law Firm, or Bronstein, Gewirtz and Grossman, LLC for more information
- Cassava Sciences, Inc. investors can seek potential recovery under federal securities laws
Several law firms, including Levi & Korsinsky, Pomerantz Law Firm, and Bronstein, Gewirtz and Grossman, LLC, have filed class action lawsuits against Cassava Sciences, Inc. (SAVA) for alleged securities fraud. The lawsuits seek to recover damages on behalf of investors who purchased or acquired Cassava securities between February 7, 2024, and November 24, 2024, the Class Period.
Investors who suffered losses on their Cassava Sciences, Inc. investment during the specified period are advised to contact the law firms before the impending deadline on February 10, 2025. Joseph E. Levi, Esq., Danielle Peyton, and other representatives are available to provide information and discuss potential recoveries under the federal securities laws.
The lawsuits claim that Cassava Sciences, Inc. and certain officers violated federal securities laws during the Class Period. Shareholders who lost money on their investments in the company are urged to take action and explore their legal options. By contacting the mentioned law firms, investors can stay informed about the pending class action suit and how it may impact their rights.
With the lead plaintiff deadline approaching, Cassava Sciences, Inc. investors should be proactive in seeking guidance on how to proceed with the securities fraud class action lawsuit. The law firms handling the case are dedicated to assisting affected shareholders and providing necessary information for them to make informed decisions regarding their potential recovery.
In light of the ongoing developments surrounding the securities fraud class action lawsuit against Cassava Sciences, Inc., investors are strongly encouraged to reach out to Levi & Korsinsky, Pomerantz Law Firm, or Bronstein, Gewirtz and Grossman, LLC, to stay informed about the legal proceedings and protect their rights as shareholders in the company. By acting promptly, investors can ensure they are properly represented and have a chance of seeking potential recovery under the federal securities laws.
For more information:
Ask the market a question. Get a calculated answer.
The AI is not a chatbot bolted onto a document store. It calls the same analytics engine that powers every screen on this platform — so what comes back is a number it computed from raw history, with the command that produced it.
86,000+ instruments
Global equities, ETFs, funds, options, FX, commodities, crypto, economics, filings, transcripts and news — one normalised symbol universe with adjusted history.
A real analytics engine
Screening, backtesting, technicals, options analytics, correlations, seasonality and factor models — computed on demand from raw prices, never a stale cache.
It shows its working
Answers arrive with the charts, tables and tool calls behind them, so you can check the number instead of trusting a paraphrase.
Your own documents
Upload filings, decks and research. Ask across them and the answer cites the page it came from.
Agents and workflows
Multi-step research that runs the platform's tools for you — screen, pull the history, compute, compare, then write it up.
MCP, CLI and API
The same command catalogue from Claude, your own agent, a shell or your pipeline. The answer on screen is the answer your job gets at 4am.
You ask
“How does NVDA usually trade through earnings?”
It calls
→ ka.options_expected_move(NVDA)
It answers
NVDA has averaged a 9.2% absolute move on the day after earnings and closed higher 67% of the time. Two in three reactions land between −4.2% and +16.3% — the distribution is skewed right, not symmetric.
Every figure computed live from our own history — not scraped, not summarised.
Or start with